Best GLP-1 programs for first-time patients: routes before the first supply
A first GLP-1 prescription needs more than a quick product choice. Medical history, current medicines, the exact preparation and a plan for reviewing response all ma
Article updated
Read this firstArticle updated November 13, 2026; source dates below
A first-time patient needs a clear evaluation, product explanation and contact route before the first delivery.
Assessment
Medical history
A clinician determines whether a prescription fits.
Order
Named product and total
Establish preparation, pharmacy and charge before commitment.
Delivery
Label and contact
Resolve storage, device and instruction questions.
A first GLP-1 prescription needs more than a quick product choice. Medical history, current medicines, the exact preparation and a plan for reviewing response all matter. These seven routes show how assessment, payment and eventual supply can be organized for someone beginning the conversation.
Injection Index compares the care doorway rather than promising eligibility or results. An intake form is not a prescription, and a fast advertised delivery is not a guarantee that the treatment fits. The patient should understand the proposed medicine and instructions before any supply is used.
Semaglutide $948/year ($79/mo equivalent) or $139 month-to-month; tirzepatide terms differ
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
GLP-1 from $89; GLP-1 plus GIP from $149; selected preparation and terms apply
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
The most useful first-order details identify who reviews the history, who writes the prescription, who dispenses it and who explains the instructions. An efficient web form can help collect information, but completion is not the same event as clinical approval.
Ask the provider to explain the product’s approval status and why it fits the clinical situation. Before payment, save the total and the rule for medical ineligibility. Before use, have any label, device or storage question resolved by the appropriate professional.
Before you decide
Questions worth answering
Does the order on this page identify the best treatment for me?
No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.
What should I verify for this comparison?
A first-time patient needs a clear evaluation, product explanation and contact route before the first delivery. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.
Evidence behind this page
Sources & chart notes
Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
Best GLP-1 programs for first-time patients: routes before the first supply — keep the next order, remaining supply and current instructions together.
What makes this shortlist useful
Prepare the health history and ask what additional assessment may be needed. Compare the actual medicine, dispensing pharmacy, initial charge and rules if prescribing is declined. For a vial, written instructions should identify concentration, prescribed amount and storage. Ask who handles questions before the first use and how follow-up is arranged rather than choosing by the shortest intake slogan. Read the related care guide for a wider treatment discussion.
What makes this shortlist useful — keep the exact product identity and its complete label together.
1. CoreAge Rx: a compounded route to explain
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. The first conversation should establish why the actual compounded preparation is appropriate. Ask about the pharmacy, labeled amount and refund cutoff before assuming a straightforward monthly offer answers the clinical or first-order questions.
Ask why the actual compounded preparation is appropriate, which pharmacy will dispense it and what the complete labeled supply contains. Confirm the point at which a prepared order becomes non-refundable and who reviews the next prescription. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Read the SuperHealthy Rx review.
SuperHealthy Rx: compare the selected agreement with the questions in this section.
3. Likeness Rx — GLP-1 weight care
Read the preparation and recurring invoice together. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
4. Ro: a branded-access membership model
Ro’s Body route separates a clinical membership from medication. The current page describes access to FDA-approved products, insurance support, provider messaging and care. That structure is useful to compare with medicine-inclusive bundles, while a membership floor alone does not identify the total treatment cost. Ro separates initial care access from medicine selection and cost. A first-time patient should know which approved product is proposed and how the membership and pharmacy charges are handled after eligibility review.
Ask for the selected membership term, full advance payment and separate pharmacy amount. Confirm which clinical access, insurance assistance and monitoring are included, and how the prescription and next payment change if the treatment plan is adjusted. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full Ro review to compare the care pathway, prescription and recurring order.
Ro: compare the selected agreement with the questions in this section.
5. Mochi Health: membership before a separate medication quote
Mochi combines provider access and nutrition-oriented support with a separate medication charge. Its current catalogue distinguishes branded medicines and compounded options. The exact selected medicine and diagnostics are outside the membership, so a product-card floor should not be mistaken for the complete monthly plan. Mochi’s physician and support model can be compared when continuing guidance matters. Identify the proposed medicine and full diagnostic or supply charges, since the new-member membership discount does not include every first-treatment expense.
Ask for the actual medicine and diagnostics quotation beside membership. Confirm availability in the patient’s state, who provides clinical and nutrition guidance and what the selected supply costs after any new-member access discount ends. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. AltRx describes a free assessment and prescribing review before appropriate pharmacy supply. Confirm the actual preparation and amount, and keep the conditional clinical decision separate from a prominent low-price card.
Ask which specific compounded or branded product is being quoted and what supply amount is included. Confirm the recurring order and clinical support, rather than assuming the lowest GLP-1 card price applies to every preparation or plan. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
7. Enhance.MD: a program with a different renewal bill
Enhance.MD connects clinician-directed compounded programs with a four-week supply, support and stated laboratory inclusion. Its semaglutide and tirzepatide offers have separate introductory and later prices. The different program names and supply periods should remain visible when the ongoing care budget is compared. Enhance’s first-month offer needs its later four-week rate visible from the beginning. Ask how the selected program is prescribed and reviewed, without allowing the introductory charge to define a long-term care budget.
Ask for the first and later four-week totals, the actual prescription and shipment terms. Confirm how stated laboratory inclusion works and who handles a change in symptoms, keeping program claims separate from evidence for the finished compound. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Choose the route that can explain the prescription, complete invoice and next review clearly. Before using the first supply, resolve any uncertainty about label, measurement or storage with the clinician or pharmacist. A patient should not improvise instructions because a comparison page or marketing image looks familiar.
FDA has reported compounded GLP-1 dosing errors and other concerns. Approved-product trial results do not establish outcomes for every custom preparation. Payment, state availability and an online qualifier do not guarantee that any requested treatment will be prescribed.
Original references are retained below. Later observations and their source dates are identified in the dated updates and research notes. Advertising describes an offer; it is not independent verification of treatment outcomes.